MedPath

A clinical trial to study the effect of trial drug sundii chooranam on kumbavatham (periarthritis)

Phase 2
Not yet recruiting
Conditions
Synovitis and tenosynovitis, unspecified,
Registration Number
CTRI/2019/05/019142
Lead Sponsor
Govenment siddha medical college and hospital
Brief Summary

The study is open labeled non randomized phase II clinical trial to evaluate the therapeutic efficacy of trial drug sundii chooranam 45mg/kg/BW two times a day with hot water for 45 days in 60 patients during the period of 14months that will be conducted in government siddha medical college and hospital palayamkottai tamilnadu

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Patient having main symptoms of shoulder joint pain restricted movement of upperlimbs loss of abduction and stiffness Diabetes mellitus Willing for doing lab investigation x-ray imaging.

Exclusion Criteria

Age below 29 and above 61years Rheumatoid arthritis Ischaemic heart disease Hypertension Pregnancy and lactating mother Recent shoulder dislocation Sub acromial bursitis.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction ot the signs and symptoms of shoulder joint pain restricted movements of the upper limbs loss of abduction and forward flexion and stiffness of shoulder joint45 days
Secondary Outcome Measures
NameTimeMethod
Achieving better oxford shoulder score (40-48)45 days

Trial Locations

Locations (1)

Govt siddha medical college and hospital

🇮🇳

Tirunelveli, TAMIL NADU, India

Govt siddha medical college and hospital
🇮🇳Tirunelveli, TAMIL NADU, India
Soundharya P
Principal investigator
9789798105
paulsoundharya93@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.